| __timestamp | Amphastar Pharmaceuticals, Inc. | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 40373000 | 6795238 |
| Thursday, January 1, 2015 | 46974000 | 7454247 |
| Friday, January 1, 2016 | 47298000 | 10345862 |
| Sunday, January 1, 2017 | 50918000 | 16984203 |
| Monday, January 1, 2018 | 58044000 | 16187290 |
| Tuesday, January 1, 2019 | 63109000 | 9299233.54 |
| Wednesday, January 1, 2020 | 65157000 | 19232000 |
| Friday, January 1, 2021 | 68920000 | 23611000 |
| Saturday, January 1, 2022 | 66592000 | 26700000 |
| Sunday, January 1, 2023 | 80393000 | 28215000 |
Data in motion
In the ever-evolving pharmaceutical industry, understanding the financial dynamics of companies is crucial. Over the past decade, Amphastar Pharmaceuticals, Inc. has consistently outpaced Summit Therapeutics Inc. in Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Amphastar's SG&A expenses grew by approximately 99%, peaking in 2023. In contrast, Summit's expenses increased by about 315% during the same period, reflecting its strategic investments in growth.
Amphastar's steady rise in expenses, with a notable 23% jump in 2023, underscores its commitment to expanding its market presence. Meanwhile, Summit's expenses surged, particularly between 2016 and 2023, indicating aggressive scaling efforts. This financial trajectory highlights the contrasting strategies of these two pharmaceutical giants, offering valuable insights into their operational priorities and market positioning.
Sanofi vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Summit Therapeutics Inc. Trends and Insights
Summit Therapeutics Inc. and Dr. Reddy's Laboratories Limited: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Viking Therapeutics, Inc.
Breaking Down SG&A Expenses: Summit Therapeutics Inc. vs Amicus Therapeutics, Inc.
Summit Therapeutics Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Summit Therapeutics Inc. and Mesoblast Limited
Insmed Incorporated vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Amphastar Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: PTC Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.: SG&A Expense Trends